Update in the management of chronic lymphocytic leukemia
Advances in the treatment of chronic lymphocytic leukemia (CLL) have improved initial overall response (OR) rates, complete response (CR) rates and progression free survival (PFS). Despite these advances, CLL remains incurable with standard therapies. Thus, there remains a need for more effective th...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
BioMed Central
2009
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723130/ |